MICHAEL JAMES OVERMAN to Endpoint Determination
This is a "connection" page, showing publications MICHAEL JAMES OVERMAN has written about Endpoint Determination.
Connection Strength
1.255
-
Discrepancies in endpoints between clinical trial protocols and clinical trial registration in randomized trials in oncology. BMC Med Res Methodol. 2018 12 12; 18(1):169.
Score: 0.607
-
Ethics and the Underreporting of Research Biopsy Findings in Clinical Trials. JAMA Oncol. 2018 08 01; 4(8):1041-1042.
Score: 0.592
-
Secondary Endpoint Utilization and Publication Rate among Phase III Oncology Trials. Cancer Res Commun. 2024 Aug 01; 4(8):2183-2188.
Score: 0.056